Marlen H.
- Country
- Germany
- Department
- Strahlenklinik
Research Overview
- A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)
- Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
- Phase 3 Evaluation of Dostarlimab Sequential Therapy Post-Chemoradiation in Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Data & Insights
Has run more than one trial at 139 of 392 partner sites.
Specializations
Head and Neck Cancer Research
This investigator specializes in treating head and neck squamous cell carcinoma (HNSCC), with particular focus on locally advanced stages III-IVA. Their research encompasses both resectable and unresectable cases, including specific work with EBV-positive nasopharyngeal carcinoma.
- Neoadjuvant Therapy Approaches
- Post-Chemoradiation Treatment Strategies
- PD-L1 Expression Analysis
Lung Cancer Studies
The investigator has extensive experience in treating various forms of lung cancer, particularly focusing on stage III unresectable non-small cell lung cancer (NSCLC) and extensive stage small cell lung cancer (SCLC).
- Concurrent Chemoradiation Protocols
- Novel Combination Therapies
- Immunotherapy Integration
Therapeutic Innovations
Their research explores innovative therapeutic combinations, including immunotherapy agents and targeted molecular treatments. Special attention is given to maintenance therapy approaches and sequential treatment strategies.
- Combined Modality Treatments
- Radiotherapy Optimization
- Novel Drug Combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.